ACB Aurora Cannabis Inc.
USHealthcareAs of 2026-07-10 16:00
Why ACB matters now
Aurora Cannabis Inc. (ACB) is a US stock in Healthcare. The latest InvestLog snapshot shows $2.71 with +0.37% on the session and $167.9M in market capitalization; recent performance reads 1-month -11.21% and YTD -30.57%.
The latest financial table shown here is Q4 2026, with revenue of $38.1M, net income of $-57.0M, and EPS of $-0.99. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -14.0%.
The latest indexable market news headline is "Aurora Named to TIME Canada's Best Companies 2026 List" from PRNewsWire.
Additional event context on this page matters because analyst consensus is Hold with a median target of $8.00. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
0.46
P/S
0.83
EV/EBITDA
16.02
DCF Value
$-25.37
FCF Yield
-14.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
56.6%
Operating Margin
0.3%
Net Margin
-24.1%
ROE
-14.1%
ROA
-12.5%
ROIC
0.1%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2026 | $38.1M | $-57.0M | $-0.99 |
| FY 2026 | $321.4M | $-122.1M | $-2.15 |
| Q3 2026 | $94.2M | $1.8M | $0.03 |
| Q2 2026 | $90.4M | $-51.5M | $-0.91 |
Analyst Ratings
Consensus
Hold
Target (Consensus)
$5.92
Target (Median)
$8.00
Target Range
$1.00 - $8.75
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
CA
Exchange
—
Beta
1.34
Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporizers. The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach. Its service portfolio extends to providing patient support, specialized design and construction services, and comprehensive analytical testing for cannabis products. Aurora Cannabis Inc. manages an extensive collection of brands, including Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. The company's main corporate office is located in Edmonton, Canada.